Robert Hofmeister
Patrimonio netto: - $ in data 31/07/2026
Patrimonio netto: - $ in data 31/07/2026
Robert Hofmeister currently works at Molkerei Hainichen Freiberg GmbH & Co. KG, as Co-Managing Director.
Dr. Hofmeister also formerly worked at Alaunos Therapeutics, Inc., as Independent Director from 2023 to 2025, EMD Serono Research & Development Institute, Inc., as Global Head-Translational Immunotherapy from 2012 to 2015, and TCR2 Therapeutics, Inc., as Senior Vice President-Research & Development.
Dr. Hofmeister received his doctorate degree from the University of Regensburg.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/04/2025 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
Molkerei Hainichen Freiberg GmbH & Co. KG
Molkerei Hainichen Freiberg GmbH & Co. KG Food: Meat/Fish/DairyConsumer Non-Durables Manufactures dairy and cheese products | Amministratore Delegato | - |
| Società | Posizione | Fine |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 15/04/2025 |
| TCR2 THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 01/03/2022 |
EMD Serono Research & Development Institute, Inc. | Corporate Officer/Principal | 01/01/2015 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
University of Regensburg
University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono Research & Development Institute, Inc. | |
Molkerei Hainichen Freiberg GmbH & Co. KG
Molkerei Hainichen Freiberg GmbH & Co. KG Food: Meat/Fish/DairyConsumer Non-Durables Manufactures dairy and cheese products | Consumer Non-Durables |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale